The comorbidities such as nephropathy and urinary tract diseases should always be considered for adjustment, because these are important risk factors for bladder cancer and are commonly seen in the diabetic patients who may have a long duration of diabetes and happen to use insulin. This evidence concerns the gene INS and Nephropathy.